{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:04:00Z","timestamp":1785798240568,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A global surplus of coronavirus disease 2019 (COVID-19) vaccines exists as a result of difficulties in aligning the demand and supply for vaccine manufacturing and delivery. World leaders have accelerated vaccine development, approval, production and distribution as a pragmatic approach to addressing the immediate public health challenges of the first two and a half years of the pandemic.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Main body<\/jats:title>\n                <jats:p>The currently predominant, highly transmissible Omicron variant of severe acute respiratory syndrome coronavirus 2 has brought us closer to the threshold required to achieve herd immunity by greatly increasing rates of natural infection. Paradoxically, in parallel with rising vaccination levels in industrialized nations, this indirectly reduces the need for mass vaccine campaigns. Principal concerns that contribute to low vaccination rates which persist in several other countries, particularly of the Global South, are vaccine hesitancy and unequal access to vaccination. Social uncertainty fueled by fake news, misinformation, unfounded lay opinions and conspiracy theories has inevitably led to an erosion of public trust in vaccination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>To address the current mismatch between supply and demand of COVID-19 vaccines, there should be a focus on three principles: decelerating vaccine production, increasing distribution across communities, and optimizing cost-effectiveness of distribution logistics. Slowing down and switching from large-scale production to effectively \u2018made to order\u2019 is a feasible option, which should be commensurate with management capacity. Transparent and evidence-based data should be widely and freely disseminated to the public through multimedia channels to mitigate miscommunication and conspiracy theories. Use of soon-to-expire stockpiles should be prioritized not only to enhance booster dose rollouts in adults but to expand immunization campaigns to children (especially those aged 5\u201311\u00a0years), subject to national approval. Future research should ideally aim to develop vaccines that only require basic, affordable storage and maintenance procedures as opposed to sophisticated and expensive protocols.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s40249-023-01070-7","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:55:27Z","timestamp":1679864127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The global COVID-19 vaccine surplus: tackling expiring stockpiles"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3222-0978","authenticated-orcid":false,"given":"Nguyen Khoi","family":"Quan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8572-6051","authenticated-orcid":false,"given":"Nguyen Le My","family":"Anh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7342-8348","authenticated-orcid":false,"given":"Andrew W.","family":"Taylor-Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,20]]},"reference":[{"key":"1070_CR1","doi-asserted-by":"publisher","first-page":"n2062","DOI":"10.1136\/bmj.n2062","volume":"374","author":"J Feinmann","year":"2021","unstructured":"Feinmann J. How the world is (not) handling surplus doses and expiring vaccines. BMJ. 2021;374:n2062.","journal-title":"BMJ"},{"issue":"4","key":"1070_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-009010","volume":"7","author":"JV Lazarus","year":"2022","unstructured":"Lazarus JV, Abdool Karim SS, van Selm L, Doran J, Batista C, Ben Amor Y, et al. COVID-19 vaccine wastage in the midst of vaccine inequity: causes, types and practical steps. BMJ Glob Health. 2022;7(4): e009010.","journal-title":"BMJ Glob Health"},{"key":"1070_CR3","unstructured":"Duke Global Health Innovation Center. Launch & Scale Speedometer: Tracking COVID-19 Vaccine Purchases Across The Globe; 2023. Available from: https:\/\/launchandscalefaster.org\/covid-19\/vaccinepurchases\/. Accessed 31 January 2023."},{"key":"1070_CR4","unstructured":"McDermott J. As Vaccine Demand Falls, States Are Left With Huge Stockpile. U.S. News & World Report; 2022. Available from: https:\/\/www.usnews.com\/news\/health-news\/articles\/2022-03-03\/as-vaccine-demand-falls-states-are-left-with-huge-stockpile\/. Accessed 31 January 2023."},{"key":"1070_CR5","unstructured":"Cohen J, Kupferschmidt K. Countries now scrambling for COVID-19 vaccines may soon have surpluses to donate. Science Insider: American Association for the Advancement of Science; 2021. Available from: https:\/\/www.science.org\/content\/article\/countries-now-scrambling-covid-19-vaccines-may-soon-have-surpluses-donate\/. Accessed 31 January 2023."},{"key":"1070_CR6","unstructured":"Wingrove J, Paton J, Sguazzin A, Bloomberg. Failure to address a global surplus of COVID vaccines raises the risk of new variants emerging, health experts warn. Fortune; 2022. Available from: https:\/\/fortune.com\/2022\/05\/11\/covid-19-vaccines-global-surplus-new-variants\/. Accessed 31 January 2023."},{"key":"1070_CR7","unstructured":"World Health Organization. Weekly epidemiological update \u2014 29 December 2020: WHO; 2022. Available from: https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update---29-december-2020. Accessed 31 January 2023."},{"key":"1070_CR8","unstructured":"World Health Organization. Coronavirus (COVID-19) Dashboard. Available from: https:\/\/covid19.who.int\/. Accessed 31 January 2023."},{"key":"1070_CR9","unstructured":"Mathieu E, Ritchie H, Rod\u00e9s-Guirao L, Appel C, Giattino C, Hasell J, et al. Coronavirus Pandemic (COVID-19). Our World in Data; 2023. Available from: https:\/\/ourworldindata.org\/coronavirus. Accessed 26 January 2023."},{"issue":"9","key":"1070_CR10","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","volume":"22","author":"OJ Watson","year":"2022","unstructured":"Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022;22(9):1293\u2013302.","journal-title":"Lancet Infect Dis"},{"key":"1070_CR11","unstructured":"Ellyatt H. Should we treat Covid like the flu? Europe is slowly starting to think so. CNBC; 2022. Available from: https:\/\/www.cnbc.com\/2022\/01\/12\/should-we-treat-covid-like-the-flu-europe-is-starting-to-think-so.html\/. Accessed 31 January 2023."},{"key":"1070_CR12","unstructured":"Gualtieri T. Spain Calls for Debate to Consider Covid as Endemic, Like Flu. Bloomberg; 2022. Available from: https:\/\/www.bloomberg.com\/news\/articles\/2022-01-11\/spain-calls-for-debate-to-consider-covid-as-endemic-like-flu\/. Accessed 31 January 2023."},{"key":"1070_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.987467","volume":"10","author":"KQ Nguyen","year":"2022","unstructured":"Nguyen KQ, Nguyen LMA, Taylor-Robinson AW. Global \u2018flu-ization\u2019 of COVID-19: a perspective from Vietnam. Front Public Health. 2022;10: 987467.","journal-title":"Front Public Health"},{"key":"1070_CR14","unstructured":"United Nations. World reaches \u2018tragic milestone\u2019 of one million COVID-19 deaths so far in 2022. UN News; 2022. Available from: https:\/\/news.un.org\/en\/story\/2022\/08\/1125462\/. Accessed 31 January 2023."},{"key":"1070_CR15","unstructured":"Agence France-Presse. WHO says Covid remains an international emergency after spike in deaths amid China outbreak. Hong Kong Free Press; 30 January 2023. Available from: https:\/\/hongkongfp.com\/2023\/01\/30\/who-says-covid-remains-an-international-emergency-after-spike-in-deaths-amid-china-outbreak\/. Accessed 31 January 2023."},{"issue":"15","key":"1070_CR16","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa2114255","volume":"385","author":"YM Bar-On","year":"2021","unstructured":"Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Kalkstein N, et al. Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel. N Engl J Med. 2021;385(15):1393\u2013400.","journal-title":"N Engl J Med"},{"issue":"8","key":"1070_CR17","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S1473-3099(22)00271-7","volume":"22","author":"APS Munro","year":"2022","unstructured":"Munro APS, Feng S, Janani L, Cornelius V, Aley PK, Babbage G, et al. Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial. Lancet Infect Dis. 2022;22(8):1131\u201341.","journal-title":"Lancet Infect Dis"},{"key":"1070_CR18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41591-022-01699-1","volume":"28","author":"N Andrews","year":"2022","unstructured":"Andrews N, Stowe J, Kirsebom F, Toffa S, Sachdeva R, Gower C, et al. Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England. Nat Med. 2022;28:831\u20137.","journal-title":"Nat Med"},{"issue":"3","key":"1070_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/qjmed\/hcac014","volume":"115","author":"SD Taylor-Robinson","year":"2022","unstructured":"Taylor-Robinson SD, Morgan MY, Spearman CW, Suliman AAA, Corrah T, Oleribe OO, et al. Why SARS-CoV-2 vaccination still matters in Africa. QJM. 2022;115(3):191\u20132.","journal-title":"QJM"},{"issue":"1","key":"1070_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102363","volume":"16","author":"MC Duong","year":"2022","unstructured":"Duong MC, Nguyen HT, Duong M. Evaluating COVID-19 vaccine hesitancy: a qualitative study from Vietnam. Diabetes Metab Syndr. 2022;16(1):102363.","journal-title":"Diabetes Metab Syndr"},{"issue":"3","key":"1070_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/00325481.2022.2044142","volume":"134","author":"G Huynh","year":"2022","unstructured":"Huynh G, Nguyen HTN, Van Tran K, Le An P, Tran TD. Determinants of COVID-19 vaccine hesitancy among parents in Ho Chi Minh City, Vietnam. Postgrad Med. 2022;134(3):303\u20138.","journal-title":"Postgrad Med"},{"issue":"8","key":"1070_CR22","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/s41591-021-01454-y","volume":"27","author":"JS Sol\u00eds Arce","year":"2021","unstructured":"Sol\u00eds Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021;27(8):1385\u201394.","journal-title":"Nat Med"},{"issue":"7","key":"1070_CR23","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.chom.2021.06.007","volume":"29","author":"A Asundi","year":"2021","unstructured":"Asundi A, O\u2019Leary C, Bhadelia N. Global COVID-19 vaccine inequity: the scope, the impact, and the challenges. Cell Host Microbe. 2021;29(7):1036\u20139.","journal-title":"Cell Host Microbe"},{"key":"1070_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1893","volume":"374","author":"E Mahase","year":"2021","unstructured":"Mahase E. Covid-19: countries dump vaccines as demand slumps and sharing proves difficult. BMJ. 2021;374: n1893.","journal-title":"BMJ"},{"key":"1070_CR25","unstructured":"Dayan S. Omne Trium Perfectum. Three may really be the charm. Modern Aesthetics. 2019; July\/August:34\u201338. Available from: https:\/\/modernaesthetics.com\/articles\/2019-july-aug\/omne-trium-perfectum\/pdf. Accessed 31 January 2023."},{"issue":"1","key":"1070_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/fampra\/cmab076","volume":"39","author":"SAM van Kessel","year":"2022","unstructured":"van Kessel SAM, Olde Hartman TC, Lucassen P, van Jaarsveld CHM. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract. 2022;39(1):159\u201367.","journal-title":"Fam Pract"},{"key":"1070_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2375","volume":"375","author":"J Feinmann","year":"2021","unstructured":"Feinmann J. COVID-19: global vaccine production is a mess and shortages are down to more than just hoarding. BMJ. 2021;375: n2375.","journal-title":"BMJ"},{"key":"1070_CR28","unstructured":"Choudhury SR. How Covid-19 vaccines can shape China and India\u2019s global influence. CNBC News; 2021. Available from: https:\/\/www.cnbc.com\/2021\/01\/29\/how-covid-19-vaccines-can-shape-china-and-indias-global-influence.html. Accessed 31 January 2023."},{"key":"1070_CR29","doi-asserted-by":"publisher","DOI":"10.2196\/40201","volume":"9","author":"S Zhao","year":"2023","unstructured":"Zhao S, Hu S, Zhou X, Song S, Wang Q, Zheng H, et al. The prevalence, features, influencing factors, and solutions for COVID-19 vaccine misinformation: systematic review. JMIR Public Health Surveill. 2023;9: e40201.","journal-title":"JMIR Public Health Surveill"},{"key":"1070_CR30","doi-asserted-by":"crossref","unstructured":"Watanabe A, Kani R, Iwagami M, Takagi H, Yasuhara J, Kuno T. Assessment of efficacy and safety of mRNA COVID-19 vaccines in children aged 5 to 11 years: a systematic review and meta-analysis. JAMA Pediatr. 2023;e226243.","DOI":"10.1001\/jamapediatrics.2022.6243"},{"issue":"1","key":"1070_CR31","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1186\/s12889-021-11725-5","volume":"21","author":"NL Alfieri","year":"2021","unstructured":"Alfieri NL, Kusma JD, Heard-Garris N, Davis MM, Golbeck E, Barrera L, et al. Parental COVID-19 vaccine hesitancy for children: vulnerability in an urban hotspot. BMC Public Health. 2021;21(1):1662.","journal-title":"BMC Public Health"},{"issue":"1","key":"1070_CR32","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1038\/s41467-021-23761-1","volume":"12","author":"L Matrajt","year":"2021","unstructured":"Matrajt L, Eaton J, Leung T, Dimitrov D, Schiffer JT, Swan DA, et al. Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination. Nat Commun. 2021;12(1):3449.","journal-title":"Nat Commun"}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-023-01070-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40249-023-01070-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-023-01070-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:56:47Z","timestamp":1679864207000},"score":1,"resource":{"primary":{"URL":"https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-023-01070-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,20]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1070"],"URL":"https:\/\/doi.org\/10.1186\/s40249-023-01070-7","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,20]]},"assertion":[{"value":"21 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}